nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—CACNA1A—nerve—amyotrophic lateral sclerosis	0.0226	0.137	CbGeAlD
Pregabalin—CACNA1A—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.0211	0.13	CbGpPWpGaD
Pregabalin—CACNA1A—hindbrain—amyotrophic lateral sclerosis	0.0169	0.103	CbGeAlD
Pregabalin—SLC1A1—hindbrain—amyotrophic lateral sclerosis	0.0165	0.1	CbGeAlD
Pregabalin—CACNA1A—brainstem—amyotrophic lateral sclerosis	0.00971	0.0588	CbGeAlD
Pregabalin—SLC1A1—brainstem—amyotrophic lateral sclerosis	0.00948	0.0574	CbGeAlD
Pregabalin—CACNA2D1—hindbrain—amyotrophic lateral sclerosis	0.00858	0.0519	CbGeAlD
Pregabalin—SLC1A1—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00845	0.0521	CbGpPWpGaD
Pregabalin—SLC1A1—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00813	0.0501	CbGpPWpGaD
Pregabalin—SLC1A1—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00725	0.0447	CbGpPWpGaD
Pregabalin—SLC1A1—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00719	0.0443	CbGpPWpGaD
Pregabalin—CACNA1A—medulla oblongata—amyotrophic lateral sclerosis	0.00677	0.041	CbGeAlD
Pregabalin—SLC1A1—spinal cord—amyotrophic lateral sclerosis	0.0059	0.0357	CbGeAlD
Pregabalin—CACNA1A—nervous system—amyotrophic lateral sclerosis	0.00509	0.0308	CbGeAlD
Pregabalin—CACNA1A—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.00503	0.031	CbGpPWpGaD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00498	0.0307	CbGpPWpGaD
Pregabalin—SLC1A1—nervous system—amyotrophic lateral sclerosis	0.00497	0.0301	CbGeAlD
Pregabalin—CACNA2D1—brainstem—amyotrophic lateral sclerosis	0.00492	0.0298	CbGeAlD
Pregabalin—CACNA1A—central nervous system—amyotrophic lateral sclerosis	0.0049	0.0297	CbGeAlD
Pregabalin—CACNA1A—cerebellum—amyotrophic lateral sclerosis	0.00479	0.029	CbGeAlD
Pregabalin—SLC1A1—central nervous system—amyotrophic lateral sclerosis	0.00478	0.0289	CbGeAlD
Pregabalin—SLC1A1—cerebellum—amyotrophic lateral sclerosis	0.00467	0.0283	CbGeAlD
Pregabalin—CACNA2D2—spinal cord—amyotrophic lateral sclerosis	0.00425	0.0257	CbGeAlD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00423	0.0261	CbGpPWpGaD
Pregabalin—CACNA1A—brain—amyotrophic lateral sclerosis	0.00389	0.0235	CbGeAlD
Pregabalin—SLC1A1—brain—amyotrophic lateral sclerosis	0.0038	0.023	CbGeAlD
Pregabalin—CACNA2D2—nervous system—amyotrophic lateral sclerosis	0.00358	0.0217	CbGeAlD
Pregabalin—CACNA2D2—central nervous system—amyotrophic lateral sclerosis	0.00345	0.0209	CbGeAlD
Pregabalin—CACNA2D2—cerebellum—amyotrophic lateral sclerosis	0.00337	0.0204	CbGeAlD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00308	0.019	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00284	0.0175	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00274	0.0169	CbGpPWpGaD
Pregabalin—CACNA2D2—brain—amyotrophic lateral sclerosis	0.00274	0.0166	CbGeAlD
Pregabalin—CACNA2D1—nervous system—amyotrophic lateral sclerosis	0.00258	0.0156	CbGeAlD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00251	0.0155	CbGpPWpGaD
Pregabalin—CACNA2D1—central nervous system—amyotrophic lateral sclerosis	0.00248	0.015	CbGeAlD
Pregabalin—CACNA2D1—cerebellum—amyotrophic lateral sclerosis	0.00242	0.0147	CbGeAlD
Pregabalin—SLC1A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00236	0.0145	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00233	0.0144	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00233	0.0144	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00223	0.0137	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00222	0.0137	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00218	0.0134	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0021	0.013	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00208	0.0128	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00205	0.0127	CbGpPWpGaD
Pregabalin—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00302	CcSEcCtD
Pregabalin—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00299	CcSEcCtD
Pregabalin—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00299	CcSEcCtD
Pregabalin—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00295	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00198	0.0122	CbGpPWpGaD
Pregabalin—CACNA2D1—brain—amyotrophic lateral sclerosis	0.00197	0.0119	CbGeAlD
Pregabalin—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00292	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00192	0.0118	CbGpPWpGaD
Pregabalin—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00286	CcSEcCtD
Pregabalin—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00286	CcSEcCtD
Pregabalin—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00283	CcSEcCtD
Pregabalin—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00283	CcSEcCtD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00189	0.0117	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00187	0.0115	CbGpPWpGaD
Pregabalin—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00277	CcSEcCtD
Pregabalin—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00274	CcSEcCtD
Pregabalin—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00274	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00181	0.0112	CbGpPWpGaD
Pregabalin—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00266	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00179	0.011	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00179	0.011	CbGpPWpGaD
Pregabalin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00263	CcSEcCtD
Pregabalin—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00263	CcSEcCtD
Pregabalin—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00263	CcSEcCtD
Pregabalin—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00261	CcSEcCtD
Pregabalin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00261	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00175	0.0108	CbGpPWpGaD
Pregabalin—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00259	CcSEcCtD
Pregabalin—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00259	CcSEcCtD
Pregabalin—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00256	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00172	0.0106	CbGpPWpGaD
Pregabalin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00254	CcSEcCtD
Pregabalin—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00254	CcSEcCtD
Pregabalin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00254	CcSEcCtD
Pregabalin—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00254	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00171	0.0105	CbGpPWpGaD
Pregabalin—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00251	CcSEcCtD
Pregabalin—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00251	CcSEcCtD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00169	0.0104	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00169	0.0104	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00169	0.0104	CbGpPWpGaD
Pregabalin—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00249	CcSEcCtD
Pregabalin—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00249	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00166	0.0102	CbGpPWpGaD
Pregabalin—Mania—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00247	CcSEcCtD
Pregabalin—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00243	CcSEcCtD
Pregabalin—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00241	CcSEcCtD
Pregabalin—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00241	CcSEcCtD
Pregabalin—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00239	CcSEcCtD
Pregabalin—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00239	CcSEcCtD
Pregabalin—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00239	CcSEcCtD
Pregabalin—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00239	CcSEcCtD
Pregabalin—SLC1A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00159	0.00982	CbGpPWpGaD
Pregabalin—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00235	CcSEcCtD
Pregabalin—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00235	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00157	0.0097	CbGpPWpGaD
Pregabalin—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00233	CcSEcCtD
Pregabalin—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00231	CcSEcCtD
Pregabalin—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00227	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00152	0.00937	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00152	0.00937	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0015	0.00926	CbGpPWpGaD
Pregabalin—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00223	CcSEcCtD
Pregabalin—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00223	CcSEcCtD
Pregabalin—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00222	CcSEcCtD
Pregabalin—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00222	CcSEcCtD
Pregabalin—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00218	CcSEcCtD
Pregabalin—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00218	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00143	0.00881	CbGpPWpGaD
Pregabalin—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00212	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00141	0.00871	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00141	0.00871	CbGpPWpGaD
Pregabalin—Delirium—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00209	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00139	0.00857	CbGpPWpGaD
Pregabalin—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00206	CcSEcCtD
Pregabalin—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00204	CcSEcCtD
Pregabalin—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00203	CcSEcCtD
Pregabalin—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00135	0.002	CcSEcCtD
Pregabalin—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00199	CcSEcCtD
Pregabalin—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00199	CcSEcCtD
Pregabalin—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00198	CcSEcCtD
Pregabalin—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00198	CcSEcCtD
Pregabalin—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00196	CcSEcCtD
Pregabalin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00196	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00132	0.00813	CbGpPWpGaD
Pregabalin—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00195	CcSEcCtD
Pregabalin—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00194	CcSEcCtD
Pregabalin—Gout—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00192	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00129	0.00796	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00129	0.00796	CbGpPWpGaD
Pregabalin—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00191	CcSEcCtD
Pregabalin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0019	CcSEcCtD
Pregabalin—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0019	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00127	0.00785	CbGpPWpGaD
Pregabalin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00189	CcSEcCtD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00126	0.00776	CbGpPWpGaD
Pregabalin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00184	CcSEcCtD
Pregabalin—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00183	CcSEcCtD
Pregabalin—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00183	CcSEcCtD
Pregabalin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00182	CcSEcCtD
Pregabalin—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0018	CcSEcCtD
Pregabalin—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0018	CcSEcCtD
Pregabalin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0018	CcSEcCtD
Pregabalin—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0018	CcSEcCtD
Pregabalin—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00179	CcSEcCtD
Pregabalin—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00177	CcSEcCtD
Pregabalin—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00175	CcSEcCtD
Pregabalin—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00173	CcSEcCtD
Pregabalin—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00173	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00117	0.00718	CbGpPWpGaD
Pregabalin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00171	CcSEcCtD
Pregabalin—CACNA1A—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00115	0.0071	CbGpPWpGaD
Pregabalin—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00171	CcSEcCtD
Pregabalin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00169	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00113	0.00696	CbGpPWpGaD
Pregabalin—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00165	CcSEcCtD
Pregabalin—Coma—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00164	CcSEcCtD
Pregabalin—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00162	CcSEcCtD
Pregabalin—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00162	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00108	0.00667	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00108	0.00667	CbGpPWpGaD
Pregabalin—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0016	CcSEcCtD
Pregabalin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00157	CcSEcCtD
Pregabalin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00156	CcSEcCtD
Pregabalin—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00156	CcSEcCtD
Pregabalin—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00154	CcSEcCtD
Pregabalin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00153	CcSEcCtD
Pregabalin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00153	CcSEcCtD
Pregabalin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00151	CcSEcCtD
Pregabalin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0015	CcSEcCtD
Pregabalin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0015	CcSEcCtD
Pregabalin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00098	0.00146	CcSEcCtD
Pregabalin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00098	0.00146	CcSEcCtD
Pregabalin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000976	0.00145	CcSEcCtD
Pregabalin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000967	0.00144	CcSEcCtD
Pregabalin—CACNA2D2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000965	0.00595	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000961	0.00592	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000961	0.00592	CbGpPWpGaD
Pregabalin—Injury—Riluzole—amyotrophic lateral sclerosis	0.000954	0.00142	CcSEcCtD
Pregabalin—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000945	0.00141	CcSEcCtD
Pregabalin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00139	CcSEcCtD
Pregabalin—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00139	CcSEcCtD
Pregabalin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000929	0.00138	CcSEcCtD
Pregabalin—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.000925	0.00138	CcSEcCtD
Pregabalin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00137	CcSEcCtD
Pregabalin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00091	0.00135	CcSEcCtD
Pregabalin—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.000906	0.00135	CcSEcCtD
Pregabalin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000902	0.00134	CcSEcCtD
Pregabalin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000898	0.00134	CcSEcCtD
Pregabalin—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00088	0.00131	CcSEcCtD
Pregabalin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000877	0.0013	CcSEcCtD
Pregabalin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000877	0.0013	CcSEcCtD
Pregabalin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000877	0.0013	CcSEcCtD
Pregabalin—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00087	0.00129	CcSEcCtD
Pregabalin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00128	CcSEcCtD
Pregabalin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00128	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000857	0.00528	CbGpPWpGaD
Pregabalin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000856	0.00127	CcSEcCtD
Pregabalin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000846	0.00126	CcSEcCtD
Pregabalin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00124	CcSEcCtD
Pregabalin—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00124	CcSEcCtD
Pregabalin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000831	0.00124	CcSEcCtD
Pregabalin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000824	0.00123	CcSEcCtD
Pregabalin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000815	0.00121	CcSEcCtD
Pregabalin—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000809	0.0012	CcSEcCtD
Pregabalin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00119	CcSEcCtD
Pregabalin—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000798	0.00119	CcSEcCtD
Pregabalin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.000792	0.00118	CcSEcCtD
Pregabalin—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000789	0.00117	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000784	0.00483	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000784	0.00483	CbGpPWpGaD
Pregabalin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000776	0.00115	CcSEcCtD
Pregabalin—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00115	CcSEcCtD
Pregabalin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00115	CcSEcCtD
Pregabalin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000763	0.00113	CcSEcCtD
Pregabalin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000758	0.00113	CcSEcCtD
Pregabalin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000758	0.00113	CcSEcCtD
Pregabalin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000758	0.00113	CcSEcCtD
Pregabalin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000743	0.0011	CcSEcCtD
Pregabalin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000738	0.0011	CcSEcCtD
Pregabalin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000729	0.00108	CcSEcCtD
Pregabalin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00072	0.00107	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000717	0.00442	CbGpPWpGaD
Pregabalin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00105	CcSEcCtD
Pregabalin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00105	CcSEcCtD
Pregabalin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0007	0.00104	CcSEcCtD
Pregabalin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000698	0.00104	CcSEcCtD
Pregabalin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000692	0.00103	CcSEcCtD
Pregabalin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00069	0.00103	CcSEcCtD
Pregabalin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000686	0.00102	CcSEcCtD
Pregabalin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00068	0.00101	CcSEcCtD
Pregabalin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000676	0.001	CcSEcCtD
Pregabalin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000676	0.001	CcSEcCtD
Pregabalin—Depression—Riluzole—amyotrophic lateral sclerosis	0.000674	0.001	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000667	0.00411	CbGpPWpGaD
Pregabalin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00099	CcSEcCtD
Pregabalin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000662	0.000985	CcSEcCtD
Pregabalin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000662	0.000985	CcSEcCtD
Pregabalin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000659	0.000979	CcSEcCtD
Pregabalin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000659	0.000979	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000657	0.00405	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000657	0.00405	CbGpPWpGaD
Pregabalin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000657	0.000977	CcSEcCtD
Pregabalin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000648	0.000963	CcSEcCtD
Pregabalin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000644	0.000958	CcSEcCtD
Pregabalin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000637	0.000948	CcSEcCtD
Pregabalin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000634	0.000943	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000627	0.00386	CbGpPWpGaD
Pregabalin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000617	0.000918	CcSEcCtD
Pregabalin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00061	0.000907	CcSEcCtD
Pregabalin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000608	0.000904	CcSEcCtD
Pregabalin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000607	0.000902	CcSEcCtD
Pregabalin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000607	0.000902	CcSEcCtD
Pregabalin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000603	0.000897	CcSEcCtD
Pregabalin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000603	0.000897	CcSEcCtD
Pregabalin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000602	0.000895	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000601	0.0037	CbGpPWpGaD
Pregabalin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000599	0.000891	CcSEcCtD
Pregabalin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000597	0.000889	CcSEcCtD
Pregabalin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000596	0.000886	CcSEcCtD
Pregabalin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000595	0.000884	CcSEcCtD
Pregabalin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000573	0.000853	CcSEcCtD
Pregabalin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000567	0.000843	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000567	0.00349	CbGpPWpGaD
Pregabalin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000563	0.000837	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000559	0.00344	CbGpPWpGaD
Pregabalin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00055	0.000818	CcSEcCtD
Pregabalin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000548	0.000815	CcSEcCtD
Pregabalin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000547	0.000813	CcSEcCtD
Pregabalin—Chills—Riluzole—amyotrophic lateral sclerosis	0.000544	0.000809	CcSEcCtD
Pregabalin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000542	0.000806	CcSEcCtD
Pregabalin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000536	0.000797	CcSEcCtD
Pregabalin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000531	0.00079	CcSEcCtD
Pregabalin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000528	0.000785	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000525	0.00324	CbGpPWpGaD
Pregabalin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00052	0.000774	CcSEcCtD
Pregabalin—Tension—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00077	CcSEcCtD
Pregabalin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000517	0.000769	CcSEcCtD
Pregabalin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000513	0.000763	CcSEcCtD
Pregabalin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000511	0.000759	CcSEcCtD
Pregabalin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000508	0.000755	CcSEcCtD
Pregabalin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000495	0.000736	CcSEcCtD
Pregabalin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00049	0.000728	CcSEcCtD
Pregabalin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000488	0.000726	CcSEcCtD
Pregabalin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000485	0.000722	CcSEcCtD
Pregabalin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000482	0.000717	CcSEcCtD
Pregabalin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000476	0.000708	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000475	0.00293	CbGpPWpGaD
Pregabalin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000474	0.000705	CcSEcCtD
Pregabalin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000473	0.000704	CcSEcCtD
Pregabalin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000473	0.000703	CcSEcCtD
Pregabalin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000467	0.000694	CcSEcCtD
Pregabalin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000464	0.00069	CcSEcCtD
Pregabalin—Cough—Riluzole—amyotrophic lateral sclerosis	0.000461	0.000685	CcSEcCtD
Pregabalin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000457	0.00068	CcSEcCtD
Pregabalin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000456	0.000678	CcSEcCtD
Pregabalin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000449	0.000668	CcSEcCtD
Pregabalin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000449	0.000668	CcSEcCtD
Pregabalin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000449	0.000668	CcSEcCtD
Pregabalin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000448	0.000666	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000446	0.000664	CcSEcCtD
Pregabalin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000444	0.00066	CcSEcCtD
Pregabalin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00044	0.000654	CcSEcCtD
Pregabalin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000434	0.000646	CcSEcCtD
Pregabalin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000431	0.000641	CcSEcCtD
Pregabalin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000431	0.000641	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00043	0.00265	CbGpPWpGaD
Pregabalin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000428	0.000637	CcSEcCtD
Pregabalin—Shock—Riluzole—amyotrophic lateral sclerosis	0.000424	0.00063	CcSEcCtD
Pregabalin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000423	0.000628	CcSEcCtD
Pregabalin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000422	0.000627	CcSEcCtD
Pregabalin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000421	0.000625	CcSEcCtD
Pregabalin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000419	0.000622	CcSEcCtD
Pregabalin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000417	0.000619	CcSEcCtD
Pregabalin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000411	0.000611	CcSEcCtD
Pregabalin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000403	0.000599	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000396	0.00244	CbGpPWpGaD
Pregabalin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000393	0.000584	CcSEcCtD
Pregabalin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00039	0.00058	CcSEcCtD
Pregabalin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000387	0.000575	CcSEcCtD
Pregabalin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000384	0.000571	CcSEcCtD
Pregabalin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000383	0.00057	CcSEcCtD
Pregabalin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000375	0.000557	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000372	0.000553	CcSEcCtD
Pregabalin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000372	0.000552	CcSEcCtD
Pregabalin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000368	0.000548	CcSEcCtD
Pregabalin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000368	0.000548	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00036	0.00222	CbGpPWpGaD
Pregabalin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000355	0.000528	CcSEcCtD
Pregabalin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000352	0.000524	CcSEcCtD
Pregabalin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000342	0.000509	CcSEcCtD
Pregabalin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000341	0.000507	CcSEcCtD
Pregabalin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000341	0.000507	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000332	0.00205	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000326	0.00201	CbGpPWpGaD
Pregabalin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000317	0.000472	CcSEcCtD
Pregabalin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000309	0.00046	CcSEcCtD
Pregabalin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000305	0.000453	CcSEcCtD
Pregabalin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000295	0.000438	CcSEcCtD
Pregabalin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000285	0.000424	CcSEcCtD
Pregabalin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000274	0.000407	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000273	0.00168	CbGpPWpGaD
Pregabalin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000272	0.000404	CcSEcCtD
Pregabalin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000271	0.000404	CcSEcCtD
Pregabalin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00027	0.000401	CcSEcCtD
Pregabalin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000256	0.000381	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000175	0.00108	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000161	0.00099	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000147	0.000903	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000135	0.00083	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—APOE—amyotrophic lateral sclerosis	0.000132	0.000815	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000111	0.000683	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.06e-05	0.000558	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.6e-05	0.000468	CbGpPWpGaD
